reimbursement The country manager of a JNJ affiliated company advocates deploying electronic healthcare techniques to transform the reach of local practitioners and speaks out about the sort of local adaptations that need to be considered when introducing new products to the Algerian market. What is your evaluation of the Algerian pharmaceutical…
R&D Lee Kyoung-Ryul has served as Chairman of SCL Healthcare Group since 2007. He discusses the diagnostic service providers’ extensive network in Korea as well as their ambitious plans to export their systems to China. What has been the most important long-term goal for you since you started? The most important…
biotech On February second, the Korean Ministry of Health and Welfare announced the start of a second round of financing to the biopharmaceutical industry, as part of the Global Pharmaceutical Industry Development Fund (GPIDF). A total of USD 123 million will be invested in Korean pharmaceutical and biotech companies for the…
pharmaceuticals With a wealth of experience in different countries around the world, Christophe Piganiol came to Korea as general manager of Zuellig Pharma in 2010. Today he discusses the importance of transparency in a volatile market and the introduction of new business models to satisfy customer demand. What were your impressions…
healthcare The co-president of a research group dedicated to Euro-Mediterranean health sector issues analyses commonalities across the North African region and calls for a coordinated response to shared challenges. He also delivers a comparative assessment of the Algerian market. What is your opinion about the evolution of the Algerian pharmaceutical industry and…
manufacturing The president of Algeria’s union for pharmaceutical operators discusses the state of the local industry and sheds light on the sets of challenges his members (both importers and domestic manufactures) face under the current context. The state expects a radical change in Algeria’s production makeup, with 70 percent of drug needs…
pharmaceuticals The general manager gives tips on how to succeed in the Algerian market and explains how there is something in it for all types of business. Can you introduce yourself, introduce the CCIAF, and how the Chamber of Commerce has evolved over times? The CCIAF is a non-profit organization, approved by…
clinical trials The country manager of a British biopharmaceutical company sheds light on Algeria’s potential for conducting clinical trials and offers his views on the quality of the country’s skilled labour. What is the record of your past fourteen months with AstraZeneca? Since I arrived, I have had two priorities. First, I implemented a new…
pharmaceuticals Boehringer Ingelheim is turning 130 in 2015. Miguel Salazar, president and country managing director for Mexico, explains how he is steering the company to bypass the currents of the ever-changing Mexican market to lead the company to enter the top five in the coming future. How has the pharmaceutical industry…
investment Besides protecting the health of Mexicans, COFEPRIS today offers an important value-added to the investment community: predictability. The organization’s commissioner shares the astonishing results of his last three years of tenure, undertaken with the priority of improving access of the population to a well-supplied drug market and making the Mexican…
biotech Biograft is the first private tissue bank in Mexico meeting the increasing demand for implants of human musculoskeletal tissue. The general director and founder discusses the vision behind the creation of Biograft, how the company mastered to overcome skepticism and the plans to expand exports and transform the company in…
pharmaceuticals The general manager of IMS Health Argentina – South Cone weighs in on why his organization plays a crucial role in the pharma industry in Argentina. How does the Argentinean market look today? The Argentinean market is a solid, mature and competitive business with a lot of potential in biotechnology…
See our Cookie Privacy Policy Here